GlassScriptPhysician profile
Jeffrey Alan Triest
NPI 1730126228
$6,636.30
in general payments reported to CMS, 2019-2025
45 companies · $542 in 2025
The $542 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,262 · 2020: $445 · 2021: $538 · 2022: $1,116 · 2023: $1,432 · 2024: $1,301 · 2025: $542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,275.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $822.71 | 2019-2025 | |
| Janssen Biotech, INC. | $696.59 | 2019-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $632.29 | 2019-2024 | Xtandi, Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $417.12 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $392.56 | 2020-2025 | Keytruda, Lynparza, Welireg |
| Ferring Pharmaceuticals INC. | $387.88 | 2019-2024 | Adstiladrin |
| Antares Pharma, INC. | $326.39 | 2020-2025 | Xyosted, Nocdurna, Tlando |
| Myriad Genetic Laboratories, INC. | $324.76 | 2021-2025 | Prolaris, Myrisk |
| Janssen Scientific Affairs, LLC | $193.98 | 2019-2024 | Pipeline, Erleada |
| Dornier Medtech America, INC | $190.76 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $187.63 | 2021-2025 | Lynparza, Evusheld |
| Dendreon Pharmaceuticals LLC | $180.87 | 2020-2025 | Provenge |
| Teleflex LLC | $154.61 | 2021-2023 | Urolift |
| Sumitomo Pharma America, INC. | $146.72 | 2023-2025 | Orgovyx, Gemtesa |
| Tolmar, INC. | $134.59 | 2023-2025 | Jatenzo, Eligard |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $131.65 | 2019-2020 | |
| Blue Earth Diagnostics | $111.68 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $109.75 | 2022-2025 | |
| Abbvie INC. | $106.10 | 2023-2025 | Botox |
| Tolmar Pharmaceuticals, INC. | $80.01 | 2019-2022 | |
| Urogen Pharma, INC. | $74.59 | 2021-2024 | Jelmyto |
| Allergan, INC. | $73.43 | 2019-2021 | |
| Travere Therapeutics, INC. | $60.90 | 2021 | |
| Coloplast Corp | $51.59 | 2022-2023 | Speedicath, Porges Coloplast |
| Amgen INC. | $47.71 | 2019-2022 | |
| Photocure INC | $47.51 | 2023-2024 | Cysview |
| Endo Pharmaceuticals INC. | $46.50 | 2019-2023 | Xiaflex |
| Axonics, INC. | $44.47 | 2022-2024 | Axonics |
| Sun Pharmaceutical Industries INC. | $44.41 | 2019-2024 | |
| Olympus America INC. | $43.98 | 2019 | |
| Medtronic, INC. | $43.51 | 2024 | Interstim |
| Halozyme INC | $39.75 | 2023 | |
| Ethicon US, LLC | $37.97 | 2023 | Harmonic, Echelon Circular, Surgiflo Hemostatic Matrix |
| 180 Medical, INC. | $36.41 | 2022-2023 | |
| Clarus Therapeutics INC. | $27.69 | 2021 | |
| Genzyme Corporation | $23.73 | 2022 | |
| Angiodynamics, INC. | $23.52 | 2025 | Nanoknife |
| Hologic Sales and Service, LLC | $22.46 | 2024 | Coolseal Generator |
| Laborie Medical Technologies Corp. | $20.70 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Tempus Ai, INC | $18.13 | 2024 | |
| Calyxo, INC. | $17.57 | 2024 | Cvac Aspiration System |
| Janssen Pharmaceuticals, INC | $17.08 | 2019 | |
| Cook Medical LLC | $15.82 | 2021 | |
| Procept Biorobotics Corporation | $14.79 | 2022 | |
| Immunitybio, INC. | $13.43 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Triest listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.